Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals

oleh: Ioannis Ntanasis-Stathopoulos, Vangelis Karalis, Aimilia D. Sklirou, Maria Gavriatopoulou, Harry Alexopoulos, Panagiotis Malandrakis, Ioannis P. Trougakos, Meletios A. Dimopoulos, Evangelos Terpos